Background: Metabolic syndrome (MetS) is a multifactorial disorder marked by obesity, dyslipidemia, hypertension, and insulin resistance, which increase the risk of cardiovascular diseases and type 2 diabetes mellitus. Genetic factors, including polymorphisms in the Melanocortin-4 receptor (MC4R) have been linked to its development, especially regarding lipid metabolism and obesity. This study aimed to investigate the association between the MC4R (rs17782313) C/T polymorphism and lipid profile in individuals with MetS compared to healthy controls.
Methods: A case-control study was conducted with 150 Iraqi participants including 75 MetS patients and 75 healthy controls. Anthropometric measurements and lipid profile were recorded. Genotypic distribution of the MC4R (rs17782313) polymorphism was analyzed using ARMSPCR. Statistical analyses assessed the correlation between MC4R
polymorphisms, lipid profile, and risk of MetS.
Results: Patients with MetS showed significantly higher BMI, waist circumference, triglycerides, total cholesterol, and low density lipoprotein (LDL) levels when compared to controls. The TT genotype of MC4R (rs17782313) was more prevalent among patients (24%) than controls (12%), associated with increased risk of MetS (OR=2.81, p=0.024). The T allele was also more common in patients (40.7%) than in controls (26%) (p=0.007, OR=1.95).
Conclusion: Findings suggest a strong association between MC4R (rs17782313) polymorphism, lipid abnormalities, and MetS. The T allele and TT genotype may serve as genetic markers for increased susceptibility. Further studies are needed to clarify the molecular mechanisms behind therapeutic interventions targeting this receptor |
- Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010 Apr;53:600-5. DOI: 10.1007/s00125-009-1620-4. PMID: 20012011.
- Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-7. DOI: 10.1242/dmm.001180. PMID: 19407331.
- Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-9. DOI: 10.1161/01.CIR.0000080897.52664.94. PMID: 12860911.
- Masoumi SJ, Nekooeian AA, Tanideh N, et al. Effect of allium porrum on streptozotocin-induced diabetes mellitus hyperglycemia and insulin resistance in male Sprague Dawley rats. Onl J Vet Res. 2020;24:573-577.
- Castelli WP. Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. Can J Cardiol. 1988;4:5A-10A. PMID: 3179802.
- Davoudpour R, Ahmadi A, Homayounfar R, et al. The Association of Diet Quality Indices with Metabolic Syndrome Components: A PERSIAN Cohort Study in Fasa, Iran. Int J Nutr Sci. 2023;8:197-206. DOI: 10.30476/IJNS.2023.99475.1244.
- Balkau B, Eschwege E. Insulin resistance: an independent risk factor for cardiovascular disease?. Diabetes Obes Metab. 1999;1:23-31. DOI: 10.1046/j.1463-1326.1999.0010s1023.x. PMID: 11220285.
- Abdollahzadeh SM, Mosallanejad AH, Babajafari S, et al. Prevalence of Metabolic Syndrome among Hospital Staff of Khalili Hospital, Shiraz, Iran. Int J Nutr Sci. 2017;2:196-202.
- Manolio TA, Pearson TA, Wenger NK, et al. Cholesterol and heart disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1990;81:1721-1733.
- Nouripour F, Hejazi N. Nordic Diet and Cardio-metabolic Diseases: A Review. Int J Nutr Sci. 2019;4:105-108. DOI: 10.30476/IJNS.2019.82686.1025.
- Barsh GS, Farooqi IS, O'rahilly S. Genetics of body-weight regulation. Nature. 2000;404:644-51. DOI: 10.1038/35007519. PMID: 10766251.
- Krashes MJ, Lowell BB, Garfield AS. Melanocortin-4 receptor–regulated energy homeostasis. Nat Neurosci. 2016;19:206-19. DOI: 10.1038/nn.4202. PMID: 26814590.
- Fatima MT, Ahmed I, Fakhro KA, et al. Melanocortin‐4 receptor complexity in energy homeostasis, obesity and drug development strategies. Diabetes Obes Metab. 2022;24:583-98. DOI: 10.1111/dom.14618. PMID: 34882941.
- Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889-94. DOI: 10.1126/science.1141634. PMID: 17434869.
- Loos RJ, Yeo GS. The bigger picture of FTO—the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10:51-61. DOI: 10.1038/nrendo.2013.227. PMID: 24247219.
- Garfield AS, Lam DD, Marston OJ, et al. Role of central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab. 2009;20:203-15. PMID: 19541496 DOI: 10.1016/j.tem.2009.02.002
- Namjou B, Marsolo K, Dodd AN, et al. Genetic associations with childhood obesity in the ECHO consortium: a meta-analysis. Nat Commun. 2021;12.
- Lubrano C, Genovesi G, Specchia P, et al. Obesity and metabolic syndrome: possible role of neuropeptide Y gene polymorphism. Int J Obes. 2003;27.
- Cecil JE, Tavendale R, Watt P, Hetherington MM, et al. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359:2558-66. DOI: 10.1056/NEJMoa0803839. PMID: 19073975.
- Schmid PM, Resch M, Lichtenauer M. The impact of dietary fat quality and quantity on metabolic syndrome. Cardiovasc Diagn Ther. 2012;2:266-275.
- Boquist S, Hamsten A, Karpe F, et al. Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men. Diabetologia. 2000;43:185-93. DOI: 10.1007/s001250050028. PMID: 10753040.
- Hosseini SE, Rezaei E, Mehrabani D, et al. Effect of pomegranate juice on lipid profile in streptozotocin-induced diabetic adult male rats. J Exp Anim Biol. 2013;2:13-20.
- Hosseini SE, Mehrabani D, Rezaei E. Effects of pomegranate juice on liver enzymes (ALT, ALP, AST) in diabetic and non-diabetic rats. J Anim Physiol Develop. 2014;24:59-64.
- Tettey P, Simpson Jr S, Taylor B, Blizzard L, et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler. 2014;20:1737-44. DOI: 10.1177/1352458514533162. PMID: 24829292.
- Palavra F, Marado D, Mascarenhas-Melo F, et al. New markers of early cardiovascular risk in multiple sclerosis patients: oxidized‐LDL correlates with clinical staging. Dis Markers. 2013;34:341-8. DOI: 10.3233/DMA-130979. PMID: 23478275.
- Zhornitsky S, McKay KA, Metz LM, et al. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord. 2016;5:53-65. DOI: 10.1016/j.msard.2015.10.005. PMID: 26856944.
- Weinstock-Guttman B, Zivadinov R, Mahfooz N, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation. 2011;8:127. DOI: 10.1186/1742-2094-8-127. PMID: 21970791.
- Ursu RI, Badiu C, Cucu N, et al. MC4R polymorphisms in inflammatory and autoimmune disease susceptibility. Genes. 2021;12:1312.
- Benjamins JA, Nedelkoska L, Lisak RP. Melanocortin receptor subtypes are expressed on cells in the oligodendroglial lineage and signal ACTH protection. J Neurosci Res. 2018;96:427-435. DOI: 10.1002/jnr.24141. PMID: 28877366.
- Namipashaki A, Razaghi-Moghadam Z, Ansari-Pour N. The essentiality of reporting Hardy-Weinberg equilibrium calculations in population-based genetic association studies. Cell J. 2015;17:187. DOI: 10.22074/cellj.2016.3711. PMID: 26199897.
|
